紅麹、入院者数１５７人に　相談数２万件超―厚労省

　小林製薬（大阪市）が製造した紅麹（べにこうじ）配合サプリメントを摂取した人から健康被害の訴えが相次いでいる問題で、厚生労働省は１日、先月３１日時点で入院者数が１５７人に上ったと発表した。死者は５人のままで変わらない。
　同省によると、同社への相談件数はのべ約２万２０００件。同省が設置したコールセンターへの相談件数はのべ１５７８件で、「（回収の）該当製品を摂取したが問題ないか」「成分表に紅麹と書かれた食品はリコール（回収）の対象か」などの問い合わせが寄せられているという。（2024/04/01-21:42）

The number of people who have been hospitalized over health problems linked to Kobayashi Pharmaceutical Co.'s supplement products containing "beni koji" red fermented rice stood at 157 as of Sunday, Japan's health ministry has said.
   The number of deaths among those who took the supplements remained at five, the ministry said Monday.
   According to the ministry, Kobayashi Pharmaceutical has received some 22,000 requests for consultations from consumers, while the ministry's call center set up in response to the issue handled a total of 1,578 cases. Callers asked about the possibility of health issues after taking products subject to recalls and about the scope of recalls of products containing beni koji.
   Also on Monday, the Japanese Society of Nephrology reported that most doctor visits by people with health problems linked to beni koji were made after the start of this year.
   According to an interim survey on 47 patients who were confirmed to have suffered health damage from supplements containing beni koji made by Kobayashi Pharmaceutical, the first doctor visit was made last November, while some 80 pct of the 47 patients visited doctors in January this year or later.